Professor Ian Davis MB BS PhD FRACP FAChPM is a medical oncologist, cancer immunologist, clinician-scientist, and NHMRC Practitioner Fellow. He is Professor of Medicine, Monash University and Eastern Health, and Head of the Eastern Health Clinical School (EHCS), where he is responsible for all clinical research within Eastern Health through the Monash Eastern Clinical Research Unit (ECRU). He holds honorary appointments with the Olivia Newton-John Cancer Research Institute (formerly Ludwig Institute for Cancer Research) and Austin Health, and is an adjunct Associate Professor of the University of Melbourne, and Associate of the University of Sydney. His primary clinical interests are in urologic cancer and in melanoma, and his primary research interests are in cancer immunology and the biology of urologic cancers. He heads the Uro-oncology Laboratory at EHCS in which basic and translational research occurs in prostate cancer, and leads the Eastern Health genitourinary cancer clinical trial program. Prof Davis is the founder of the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), member of COSA Council, and previously COSA Board director. He is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP). He is chair of the ANZUP Board and of its Scientific Advisory Committee. Prof Davis has published over 220 papers, attracted over $27M in grant funding, and been involved in over 180 clinical trials for which he was global or site Principal Investigator in over 120.